share_log

康宁杰瑞制药-B(09966.HK)8月15日举行董事会会议考虑及通过中期业绩

On August 15th, Conjugate Pharmaceuticals-B (09966.HK) held a board of directors meeting to consider and approve mid-term performance.

Gelonghui Finance ·  Aug 2 04:52

On August 2, Glorious Sun announced that Koninklijke Pharmaceutics (09966.HK) will hold a board of directors meeting on Thursday, August 15, 2024 to consider and approve the company's and its subsidiaries' interim performances for the six months ended June 30, 2024, as well as to handle other matters.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment